.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Baxter
Healthtrust
Medtronic
Cerilliant
Colorcon
US Department of Justice
Chinese Patent Office
Express Scripts
Chubb

Generated: June 23, 2017

DrugPatentWatch Database Preview

Doxapram hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxapram hydrochloride and what is the scope of doxapram hydrochloride freedom to operate?

Doxapram hydrochloride
is the generic ingredient in two branded drugs marketed by Watson Labs, Athenex Inc, and West-ward Pharms Int, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for doxapram hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: doxapram hydrochloride

Tradenames:2
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list22
Clinical Trials: see list2,251
Patent Applications: see list222
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxapram hydrochloride at DailyMed

Pharmacology for Ingredient: doxapram hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
DOXAPRAM HYDROCHLORIDE
doxapram hydrochloride
INJECTABLE;INJECTION073529-001Jan 30, 1992DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
DOPRAM
doxapram hydrochloride
INJECTABLE;INJECTION014879-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Athenex Inc
DOXAPRAM HYDROCHLORIDE
doxapram hydrochloride
INJECTABLE;INJECTION076266-001Jan 10, 2003APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Moodys
AstraZeneca
Queensland Health
Medtronic
Teva
Citi
Deloitte
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot